BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20721781)

  • 21. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New tests for null hypothesis of non unity ratio of proportions.
    Koti KM
    J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method.
    Kang SH; Tsong Y
    Stat Med; 2010 Jun; 29(14):1477-87. PubMed ID: 20535762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-inferiority test and confidence interval for the difference in correlated proportions in diagnostic procedures based on multiple raters.
    Saeki H; Tango T
    Stat Med; 2011 Dec; 30(28):3313-27. PubMed ID: 21953516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.
    Kosinski AS; Chen Y; Lyles RH
    Stat Med; 2010 Jul; 29(15):1572-9. PubMed ID: 20552570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hierarchical testing of multiple endpoints in group-sequential trials.
    Glimm E; Maurer W; Bretz F
    Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the Gould-Shih procedure for sample size re-estimation.
    Waksman JA
    Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
    Goeman JJ; Solari A; Stijnen T
    Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bootstrap standard error and confidence intervals for the correlations corrected for indirect range restriction.
    Li JC; Chan W; Cui Y
    Br J Math Stat Psychol; 2011 Nov; 64(3):367-87. PubMed ID: 21973092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new test of non-inferiority for anti-infective trials.
    Phillips KF
    Stat Med; 2003 Jan; 22(2):201-12. PubMed ID: 12520557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interim treatment selection with a flexible selection margin in clinical trials.
    Wu Y; Zhao PL
    Stat Med; 2013 Jul; 32(15):2529-43. PubMed ID: 23212767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal design of clinical trials comparing several treatments with a control.
    Marschner IC
    Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inference on treatment effects for targeted clinical trials under enrichment design.
    Liu JP; Lin JR; Chow SC
    Pharm Stat; 2009; 8(4):356-70. PubMed ID: 19180519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials.
    Hall DB; Meier U; Diener HC
    Contemp Clin Trials; 2005 Jun; 26(3):349-64. PubMed ID: 15911469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.